Posted June 28, 2018 07:29:00A team of researchers in Canada has developed a new bioelectrical blood test that uses a computer to generate and interpret blood-oxygen-level-dependent electrical signals.
The test is the first of its kind to use computer technology to analyze and interpret the electrical signals produced by the human heart.
“We were looking at a whole range of different things, but this one was specifically focused on the electrical signal from the heart,” said study leader and postdoctoral fellow in the Department of Electrical Engineering and Computer Science, Michael Cairns.
Cairns is lead author of the study published in the Journal of Biological Chemistry.
“It’s a really novel approach to the problem of determining what the electrical response of a blood vessel is,” said lead author and postdoc David Sall, also from the department of electrical engineering and computer science.
The research is part of a larger effort by the Canadian Medical Association to create a unified national body for medical research.
Cairn is a member of the AMA committee on bioelectronics.
“This is something that’s been a bit of a bit out of the way for a while, so I think it’s nice to have this as part of the national initiative,” said Sall.
“What we’re trying to do is bring together a broad group of researchers who have expertise in this area, and hopefully we can help to make this a very attractive science.”
Sall, who is also a postdoctoral researcher at the University of Calgary, said the project is not meant to replace the work of the medical professionals that use the device.
“These are tools that are being used in the lab, so we’re not really talking about replacing them,” he said.
“What we want to do in this project is make it easier to test for these kinds of issues.”
I think there are a lot of people out there who are using these tools to test these issues, and the goal is to try and make them more accessible and more affordable,” he added.
Sall said the team is working on a prototype of the device and is looking to commercialize the product in the coming year.